Bioservo Technologies AB releases the interim report for the second quarter and new financial targets
The board of Bioservo AB (publ) ("Bioservo" or the "Company") today releases the Company's interim report for the second quarter 2022 and new financial targets for 2025 based on the increased interest from industrial segment in the US and the upcoming launch of Carbonhand 2.0 in the health care segment. According to the new targets, Bioservo will reach a revenue of SEK 100 million and a positive cash flow during 2025.Second quarter in figures · Net sales of SEK 3.6 M (1.0) · EBITDA of SEK -11.0 M (-9.6) · EBIT of SEK –11.8 M (-10.9) · Earnings for the period amounted to SEK -